OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients

OGDHL Expression as a Prognostic Biomarker for Liver Cancer Patients

Background and Objective. Liver cancer is a highly malignant tumor, and patients typically have poor prognoses. Metabolic reprogramming is a hallmark of cancer, and downregulation of oxoglutarate dehydrogenase-like (OGDHL) contributes to the onset and progression of several cancers. We examined the...

Full description

Bibliographic Details
Main Authors: Yan Jiao, Yanqing Li, Zhuo Fu, Lin Hou, Qingmin Chen, Yujie Cai, Peiqiang Jiang, Miao He, Zhaoying Yang
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2019/9037131

Similar Items

Similar Items